Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

BIORA THERAPEUTICS, INC. (PROG)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Net income    -117.3-155.9-229.0-247.4-230.1-233.4
Depreciation and amortization    1.11.01.31.41.41.6
Change in working capital   [+]  -5.7-14.6-7.2-2.0-38.8-19.9
Other operating activities    19.935.9103.0107.6130.5115.4
Cash from operations    -102.0-133.6-131.8-140.3-137.0-136.3
   
Capital expenditures    0.70.60.80.93.04.0
Other cash from investing    -1.2-1.3-1.9-2.1-6.5-8.4
Cash from investing    -0.5-0.8-1.1-1.2-3.5-4.3
   
Issuance of common stock, net    29.828.238.846.849.548.9
Other cash from financing    46.581.4107.2118.3146.0114.0
Cash from financing    76.3109.6146.0165.0195.5162.9
   
Free cash flow    -101.3-133.1-131.1-139.5-133.9-132.2
        Per share (diluted)    ($1.36)($2.57)($1.99)($1.78)($2.19)($2.70)
   
Cash paid for interest     9.3 7.52.55.1
Cash paid for income taxes    0.00.30.4 0.40.1

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy